A thought that I just had, but I expect Anavex has had for a while: can a precision drug be designed for each of the 4 genetic combinations, so that each group would be super responders for one drug. Assuming Blarcamesine is that for Sigmar1 Wild Type and COL24A1 Base, need 3 more drugs for the other 3 genetic combinations. Not sure if that is a "tweak" of Blarcamesine, or design from scratch. If Anavex could patent this space, that would be monumental.